Aliskiren (Tekturna) Gets New Warning and Contraindication From FDA Forbes The FDA now states that these drug combinations are contraindicated in patients with diabetes, and it is adding a new warning to avoid the use of this combination in patients with moderate to severe renal impairment (GFR <60 mL/min). New Warning, Contraindications Announced for Aliskiren-Containing Drugs Family Practice News Digital Network No aliskiren with ACE inhibitors, ARBs in some patients: FDA TheHeart.Org FDA Warns of Aliskiren Combos MedPage Today Reuters  - Cardiovascular Business  - Bioscience Technology all 19 news articles »

...